Business & Finance STAAR Surgical Company; FDA Panel Recommends Approval of Visian Toric ICLBy Sean CampbellMarch 31, 2014 On Friday the FDA hosted a panel to review Staar’s Visian Toric Implantable Collamer Lens (TICL). With the consensus recommending…
Financial Dynavax Technologies Corporation Fourth-Quarter Financials a Non-Event; Pivotal Heplisav Study Initiation ImminentBy Thomas LarsonMarch 18, 2014 Dynavax ended the fourth quarter with $189.4 million in cash, which, according to our model, should sustain operations into 2016.…